S&P 500   3,916.64
DOW   31,861.98
QQQ   305.05
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Fed's Shocking New Plan to Control Your Money (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Niinistö: Sweden security OK if Finland joins NATO first
Fed's Shocking New Plan to Control Your Money (Ad)
The End of Coca Cola's Compressed Margins
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.05
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Fed's Shocking New Plan to Control Your Money (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Niinistö: Sweden security OK if Finland joins NATO first
Fed's Shocking New Plan to Control Your Money (Ad)
The End of Coca Cola's Compressed Margins
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.05
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Fed's Shocking New Plan to Control Your Money (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Niinistö: Sweden security OK if Finland joins NATO first
Fed's Shocking New Plan to Control Your Money (Ad)
The End of Coca Cola's Compressed Margins
Enphase Energy is Still a Buy for Long-Term Growth Investors
S&P 500   3,916.64
DOW   31,861.98
QQQ   305.05
Risk-Free Money Market vs. Bank Dividend Stock, Which is Better?
Fed's Shocking New Plan to Control Your Money (Ad)
Deal for UBS to buy Credit Suisse sends shares tumbling
Gunmen kill 9 Chinese at mine in Central African Republic
Fed's Shocking New Plan to Control Your Money (Ad)
Which Gold Stocks Can Help You Hedge Bank Exposure?
Niinistö: Sweden security OK if Finland joins NATO first
Fed's Shocking New Plan to Control Your Money (Ad)
The End of Coca Cola's Compressed Margins
Enphase Energy is Still a Buy for Long-Term Growth Investors
NASDAQ:ABIO

ARCA biopharma - ABIO Stock Forecast, Price & News

$2.14
+0.01 (+0.47%)
(As of 03/17/2023 06:55 PM ET)
Add
Compare
Today's Range
$2.05
▼
$2.14
50-Day Range
$2.02
▼
$2.49
52-Week Range
$1.76
▼
$2.70
Volume
60,700 shs
Average Volume
31,710 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ABIO stock logo

About ARCA biopharma (NASDAQ:ABIO) Stock

ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of targeted therapies for cardiovascular diseases. The firm focuses on the cardiovascular pathophysiology, molecular genetics, and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Stock News Headlines

March 19, 2023 | americanbankingnews.com
StockNews.com Initiates Coverage on ARCA biopharma (NASDAQ:ABIO)
March 11, 2023 | americanbankingnews.com
ARCA biopharma (NASDAQ:ABIO) Coverage Initiated at StockNews.com
March 20, 2023 | Oxford Club (Ad)
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
March 10, 2023 | msn.com
Can Frankie Muniz Contend at Phoenix After His Impressive ARCA Debut?
February 24, 2023 | finance.yahoo.com
ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
February 18, 2023 | foxnews.com
Frankie Muniz finishes 11th in ARCA debut at Daytona International Speedway
February 14, 2023 | msn.com
ARCA gets funding for new 40-foot mobile clinic, helps end surge of drug overdose deaths in St. Louis region
January 11, 2023 | foxnews.com
Frankie Muniz to race in ARCA Menards Series
March 20, 2023 | Weiss Ratings (Ad)
Urgent Warning
This was never meant for the general public. But it’s all there in black and white … A frightening plan that gives the Fed the power to track and even control your checking account, including ALL your financial transactions. A pilot test program is already underway. And it’s slated to launch at America’s largest banks as soon as May of this year! So, time to prepare is very short. Fortunately, there are a few key steps you can take to defend yourself …
January 11, 2023 | benzinga.com
FRANKIE MUNIZ TAKES ON 2023 ARCA MENARDS SERIES CHAMPIONSHIP IN RETTE JONES RACING NO. 30 FORD MUSTANG
January 9, 2023 | msn.com
‘Goya, Carrière and the Ghost of Buñuel’ Wins Uruguay’s ARCA
January 2, 2023 | msn.com
Featuring ‘Caravaggio,’ ‘Charlotte,’ ‘Dreaming Walls,’ Uruguay’s ARCA Kicks Off Second Edition
December 19, 2022 | finance.yahoo.com
James Flynn Joins ARCA biopharma Board of Directors
November 14, 2022 | finance.yahoo.com
One ARCA biopharma, Inc. (NASDAQ:ABIO) insider upped their stake by 5,155% in the previous year
October 29, 2022 | finanznachrichten.de
ARCA biopharma, Inc.: ARCA biopharma Announces Third Quarter 2022 Financial Results
October 28, 2022 | finance.yahoo.com
ARCA biopharma Announces Third Quarter 2022 Financial Results
October 13, 2022 | msn.com
Mother, daughter set to compete in ARCA West race in Las Vegas
October 9, 2022 | foxnews.com
ARCA race ends with tempers flaring between Sammy Smith, Jesse Love
October 7, 2022 | msn.com
How to Watch NASCAR, Formula 1, ARCA and Everything Else in Racing This Weekend, October 8-9
September 20, 2022 | seekingalpha.com
ABIO ARCA biopharma, Inc.
September 15, 2022 | foxnews.com
ARCA driver Toni Breidinger becomes Victoria's Secret model: 'Little me is crying'
September 14, 2022 | msn.com
NASCAR returns to Milwaukee Mile with Craftsman Truck and ARCA series
September 11, 2022 | msn.com
Corey Heim bows out of ARCA series with Kansas Speedway win
September 4, 2022 | msn.com
Du Quoin State Fair ARCA Menards Series event postponed due to wet conditions
August 26, 2022 | tmcnet.com
SESAMI WELCOMES GLOBAL LEADER ARCA AS IT STRENGTHENS ITS GLOBAL LEADERSHIP IN CASH AUTOMATION SOLUTIONS
August 18, 2022 | msn.com
How to watch Watkins Glen ARCA Menards race: Time, TV channel, free live stream
August 2, 2022 | finance.yahoo.com
ARCA biopharma Announces Second Quarter 2022 Financial Results
See More Headlines
Receive ABIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARCA biopharma and its competitors with MarketBeat's FREE daily newsletter.

ABIO Company Calendar

Last Earnings
8/04/2021
Today
3/20/2023
Next Earnings (Estimated)
5/01/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABIO
CUSIP
N/A
CIK
907654
Web
arcabio.com
Phone
(720) 940-2100
Fax
720-208-9261
Employees
17
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($0.69)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-9,930,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-22.39%
Return on Assets
-21.21%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
37.72
Quick Ratio
37.72

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
0.74

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
1.47

Key Executives

  • Michael R. Bristow
    President, Chief Executive Officer & Director
  • Thomas A. Keuer
    Chief Operating Officer
  • C. Jeffrey Dekker
    Chief Financial Officer
  • Christopher David OzeroffChristopher David Ozeroff
    Secretary, Senior Vice President & General Counsel
  • Sharon Perry
    Vice President-Regulatory Affairs & Quality

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













ABIO Stock - Frequently Asked Questions

How have ABIO shares performed in 2023?

ARCA biopharma's stock was trading at $2.37 on January 1st, 2023. Since then, ABIO stock has decreased by 9.7% and is now trading at $2.14.
View the best growth stocks for 2023 here.

When is ARCA biopharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 1st 2023.
View our ABIO earnings forecast.

How were ARCA biopharma's earnings last quarter?

ARCA biopharma, Inc. (NASDAQ:ABIO) issued its quarterly earnings data on Wednesday, August, 4th. The biopharmaceutical company reported ($0.34) earnings per share for the quarter, topping analysts' consensus estimates of ($2.37) by $2.03.

What is Michael R. Bristow's approval rating as ARCA biopharma's CEO?

1 employees have rated ARCA biopharma Chief Executive Officer Michael R. Bristow on Glassdoor.com. Michael R. Bristow has an approval rating of 100% among the company's employees. This puts Michael R. Bristow in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of ARCA biopharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARCA biopharma investors own include Aurora Cannabis (ACBFF), MannKind (MNKD), Bausch Health Companies (BHC), Biocept (BIOC), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO), Nabriva Therapeutics (NBRV) and Synergy Pharmaceuticals (SGYP).

What is ARCA biopharma's stock symbol?

ARCA biopharma trades on the NASDAQ under the ticker symbol "ABIO."

Who are ARCA biopharma's major shareholders?

ARCA biopharma's stock is owned by a variety of retail and institutional investors. Top institutional investors include BML Capital Management LLC (5.96%), Murchinson Ltd. (0.35%), Susquehanna International Group LLP (0.00%), Jane Street Group LLC (0.10%), SG3 Management LLC (0.00%) and Group One Trading L.P. (0.00%). Insiders that own company stock include Christopher David Ozeroff, Fund Lp Funicular and Robert E Conway.
View institutional ownership trends.

How do I buy shares of ARCA biopharma?

Shares of ABIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ARCA biopharma's stock price today?

One share of ABIO stock can currently be purchased for approximately $2.14.

How can I contact ARCA biopharma?

ARCA biopharma's mailing address is 11080 CIRCLEPOINT ROAD SUITE 140, WESTMINSTER CO, 80020. The official website for the company is arcabio.com. The biopharmaceutical company can be reached via phone at (720) 940-2100, via email at derek.cole@arcabio.com, or via fax at 720-208-9261.

This page (NASDAQ:ABIO) was last updated on 3/20/2023 by MarketBeat.com Staff